Peritoneal Mast Cells in Peritoneal Dialysis Patients, Particularly in Encapsulating Peritoneal Sclerosis Patients

American Journal of Kidney Diseases

Volumn 49, Issue 3, 2007, Pages 452-461

  Alscher, Dominik M ^a   Braun, Niko ^a   Biegger, Dagmar ^b   Fritz, Peter ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

Encapsulating peritoneal sclerosis; fibrosis; mast cells; peritoneal dialysis; tryptase

Indexed keywords

NAPHTHOL AS D ESTERASE; TRYPTASE;

ADULT; AGED; APPENDICITIS; ARTICLE; CELL COUNT; CELL FUNCTION; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENCAPSULATING PERITONEUM FIBROSIS; FIBROSIS; HERNIOTOMY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; MEASUREMENT; PERITONEAL DIALYSIS; PERITONEUM MAST CELL; UPREGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APPENDICITIS; CELL COUNT; FIBROSIS; HERNIA; HUMANS; MAST CELLS; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEAL DISEASES; PERITONEUM; SCLEROSIS; TRYPTASES;

EID: 33847284001     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.11.040     Document Type: Article

References (39)

1. Williams J.D., Craig K.J., Topley N., and Williams G.T. Peritoneal dialysis: Changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl 84 (2003) S158-S161
2. Wieczorowska-Tobis K., Brelinska R., Witowski J., et al. Evidence for less irritation to the peritoneal membrane in rats dialyzed with solutions low in glucose degradation products. Perit Dial Int 24 (2004) 48-57
3. Wieczorowska-Tobis K., Polubinska A., Schaub T.P., et al. Influence of neutral-pH dialysis solutions on the peritoneal membrane: A long-term investigation in rats. Perit Dial Int 21 suppl 3 (2001) S108-S113
4. Sitter T., and Sauter M. Impact of glucose in peritoneal dialysis: Saint or sinner?. Perit Dial Int 25 (2005) 415-425
5. Cancarini G.C., Garosi G., Tanganelli P., Sassone D., and Weber E. The peritoneum during peritoneal dialysis. Perit Dial Int 20 suppl 3 (2000) S37-S86
6. Mortier S., De Vriese A.S., McLoughlin R.M., et al. Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane. J Am Soc Nephrol 14 (2003) 1296-1306
7. Nakahata T., Kobayashi T., Ishiguro A., et al. Extensive proliferation of mature connective-tissue type mast cells in vitro. Nature 324 (1986) 65-67
8. Li C.Y., and Baek J.Y. Mastocytosis and fibrosis: Role of cytokines. Int Arch Allergy Immunol 127 (2002) 123-126
9. Hawkins R.A., Claman H.N., Clark R.A., and Steigerwald J.C. Increased dermal mast cell populations in progressive systemic sclerosis: A link in chronic fibrosis?. Ann Intern Med 102 (1985) 182-186
10. Roberts I.S., and Brenchley P.E. Mast cells: The forgotten cells of renal fibrosis. J Clin Pathol 53 (2000) 858-862
11. Kondo S., Kagami S., Kido H., Strutz F., Muller G.A., and Kuroda Y. Role of mast cell tryptase in renal interstitial fibrosis. J Am Soc Nephrol 12 (2001) 1668-1676
12. Honda K., and Oda H. Pathology of encapsulating peritoneal sclerosis. Perit Dial Int 25 suppl 4 (2005) S19-S29
13. Williams J.D., Craig K.J., von Ruhland C., Topley N., and Williams G.T. The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 88 (2003) S43-S49
14. Mactier R.A. The spectrum of peritoneal fibrosing syndromes in peritoneal dialysis. Adv Perit Dial 16 (2000) 223-228
15. Nakamoto H. Encapsulating peritoneal sclerosis-A clinician's approach to diagnosis and medical treatment. Perit Dial Int 25 suppl 4 (2005) S30-S38
16. Williams J.D., Craig K.J., Topley N., et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13 (2002) 470-479
17. Fritz P., Hones J., Lutz D., et al. Quantitative immunohistochemistry: Standardization and possible application in research and surgical pathology. Acta Histochem 37 suppl 1 (1989) S213-S219
18. Fritz P., Multhaupt H., Hoenes J., et al. Quantitative immunohistochemistry. Theoretical background and its application in biology and surgical pathology. Prog Histochem Cytochem 24 (1992) 1-53
19. Wieczorowska-Tobis K., Brelinska R., Breborowicz A., and Oreopoulos D.G. Morphologic aspects of chronic peritoneal dialysis in a rat model. Perit Dial Int 21 suppl 3 (2001) S342-S344
20. Bird S.D., and Walker R.J. Mast cell histamine-induced calcium transients in cultured human peritoneal mesothelial cells. Perit Dial Int 18 (1998) 626-636
21. Zareie M., Hekking L.H., Driesprong B.A., ter Wee P.M., Beelen R.H., and van den Born J. Accumulation of omental mast cells during peritoneal dialysis. Perit Dial Int 21 suppl 3 (2001) S373-S376
22. Nakazato Y., Yamaji Y., Oshima N., Hayashi M., and Saruta T. Calcification and osteopontin localization in the peritoneum of patients on long-term continuous ambulatory peritoneal dialysis therapy. Nephrol Dial Transplant 17 (2002) 1293-1303
23. Di Paolo N., Sacchi G., Lorenzoni P., Sansoni E., and Gaggiotti E. Ossification of the peritoneal membrane. Perit Dial Int 24 (2004) 471-477
24. Zareie M., Hekking L.H., Welten A.G., et al. Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo. Nephrol Dial Transplant 18 (2003) 2629-2637
25. Zareie M., Keuning E.D., ter Wee P.M., Beelen R.H., and van den Born J. Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats. Nephrol Dial Transplant 20 (2005) 189-193
26. Qu Z., Kayton R.J., Ahmadi P., et al. Ultrastructural immunolocalization of basic fibroblast growth factor in mast cell secretory granules. Morphological evidence for bFGF release through degranulation. J Histochem Cytochem 46 (1998) 1119-1128
27. Qu Z., Liebler J.M., Powers M.R., et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 147 (1995) 564-573
28. Grutzkau A., Kruger-Krasagakes S., Baumeister H., et al. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: Implications for the biological significance of VEGF206. Mol Biol Cell 9 (1998) 875-884
29. Blair R.J., Meng H., Marchese M.J., et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 99 (1997) 2691-2700
30. Muramatsu M., Katada J., Hayashi I., and Majima M. Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model. J Biol Chem 275 (2000) 5545-5552
31. Heimburger O., Waniewski J., Werynski A., Tranaeus A., and Lindholm B. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 38 (1990) 495-506
32. Selgas R., Fernandez-Reyes M.J., Bosque E., et al. Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible?. Results of a prospective medium long-term study. Am J Kidney Dis 23 (1994) 64-73
33. Winnen P. Über Zuckergussdarm (peritonitis chronica fibrosa incapsulata). Brunns Beitr Klin Chir 123 (1921) 72
34. Margetts P.J., Kolb M., Galt T., Hoff C.M., Shockley T.R., and Gauldie J. Gene transfer of transforming growth factor-beta1 to the rat peritoneum: Effects on membrane function. J Am Soc Nephrol 12 (2001) 2029-2039
35. Margetts P.J., Kolb M., Yu L., et al. Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. Am J Pathol 160 (2002) 2285-2294
36. Nakamura S., and Niwa T. Advanced glycation end-products and peritoneal sclerosis. Semin Nephrol 24 (2004) 502-505
37. Alscher D.M., Reimold F., Schillinger-Prokorny E., Topp G., Fritz P., and Kuhlmann U. The role of transforming growth factor (TGF) in encapsulating peritoneal sclerosis (EPS). J Am Soc Nephrol 16 (2005) 265A (abstr)
38. Nakayama M. The plasma leak-to-response hypothesis: A working hypothesis on the pathogenesis of encapsulating peritoneal sclerosis after long-term peritoneal dialysis treatment. Perit Dial Int 25 suppl 4 (2005) S71-S76
39. Schwartz L.B., Bradford T.R., Littman B.H., and Wintroub B.U. The fibrinogenolytic activity of purified tryptase from human lung mast cells. J Immunol 135 (1985) 2762-2767